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Abstract
Background: Undetected depression is common in people with low vision and depression screening has been
recommended. However, depression screening is a complex procedure for which low vision practitioners need training. This
study examined the integration of routine depression screening, using two questions, and referral pathways into a national
low vision service in Wales at 6 months following practitioner training, and identified key barriers to implementation.
Methods: This pre-post single group study employed a convergent mixed methods design to collect quantitative
questionnaire and qualitative interview data on low vision practitioners’ clinical practice and perceived barriers to
implementing depression screening. Forty practitioners completed questionnaires pre-, immediately post- and 6 months
post-training and nine engaged in interviews 6 months post-training. Ordinal questionnaire scores were Rasch-transformed
into interval-level data before linear regression analyses were performed to determine the change in scores over time and
the association between perceived barriers and clinical practice. Thematic Analysis was applied to the interviews and the
narrative results merged with the questionnaire findings.
Results: Before training, only one third of practitioners (n = 15) identified depression in low vision patients, increasing to
over 90% (n = 37) at 6 months post-training, with a corresponding increase in those using validated depression screening
questions from 10% (n = 4) to 80% (n= 32). Six months post-training, practitioners reported taking significantly more
action in response to suspected depression (difference in means = 2.77, 95% CI 1.93 to 3.61, p < 0.001) and perceived less
barriers to addressing depression (difference in means = − 0.95, 95% CI − 1.32 to − 0.59, p < 0.001). However, the
screening questions were not used consistently. Some barriers to implementation remained, including perceived patient
reluctance to discuss depression, time constraints and lack of confidence in addressing depression.
Conclusions: The introduction of depression screening service guidelines and training successfully increased the number
of low vision practitioners identifying and addressing depression. However, standardized screening of all low vision
attendees has not yet been achieved and several barriers remain. Healthcare services need to address these barriers when
considering mental health screening, and further research could focus on the process from the patients’ perspective, to
determine the desire for and acceptability of screening.
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Background
Low vision is defined as vision impairment that cannot be
fully corrected with glasses, contact lenses or medical inter-
vention and causes functional restriction in a person’s every-
day life [1]. An estimated 129 million people have low vision
world-wide [2]. In the UK, 77% of people affected are aged
65 and over [3], with the leading causes being age-related
macular degeneration and glaucoma [2]. These older individ-
uals tend to have a broader range of additional physical and
mental health comorbidities compared to those without vis-
ual problems [4]. As with other chronic health conditions
[5], those with low vision are at greater risk of depression
than the general population [6, 7]. Depression in this popula-
tion is often undetected and untreated [8, 9] as a result of
the tendency for older adults to present with non-specific
somatic symptoms, which may be attributed to old age or ill-
ness [10–12]; beliefs about stigma which prevent disclosure
of mental health symptoms [11, 12]; or patient and practi-
tioner beliefs that depression is a normal response to ageing
[13] or chronic illness [14]. Chronic illness co-morbid with
depression can lead to poorer outcomes including worse
clinical symptoms and functional disability [15] and in-
creased risk of mortality [16].
A growing recognition of the increased risk and
under-detection of depression has prompted the integra-
tion of depression management into healthcare settings
and reviews in primary care. In the U.S. and Canada, na-
tional guidelines recommend routine depression screen-
ing for patients with coronary heart disease [17] and
diabetes [18] and in England, the Quality and Outcomes
Framework incentivised General Practitioners (GPs) to
screen for depression in patients with these conditions
between 2006 and 2013 [19]. Such initiatives have pro-
voked much debate about the pros and cons of routine
screening. The disadvantages include longer consulta-
tions, the potential for false positives and the possible di-
version of resources away from where they are needed
[20]. Furthermore, if screening or case-finding instru-
ments are used without any follow-up, they have little or
no impact on depression detection and outcomes [21].
However, feeding back positive results to the clinician
can improve the detection rates of depression [22], and
the feedback of positive results to the patient can reduce
the severity of depression symptoms by encouraging pa-
tients to take an active role in self-management [23].
In recent years, the low vision sector has identified an
urgent need for depression screening to be integrated
into services for people with low vision [4, 24]. In Wales,
individuals can access the Low Vision Service Wales
(LVSW), delivered by eye care professionals accredited
as low vision practitioners. Despite a 37% prevalence of
depressive symptoms in those attending the LVSW [9],
our previous work indicated that in 2018, only a third of
low vision practitioners aimed to identify depression and
only 18% used a validated screening tool to do so [25].
The majority relied on their intuition to gain a sense as
to whether a patient might be depressed. Such methods
of identifying depression were shown to be less reliable
than the use of a brief screening tool such as the PHQ-2
[26] by non-mental health professionals [27].
The UK’s National Institute for Health and Care Ex-
cellence (NICE) guidelines [28] recommend that health
practitioners be alert to possible depression in high-risk
groups. Endorsing these recommendations, the Welsh
Government’s Eye Care Delivery Plan for Wales [29]
asserted that all low vision practitioners should imple-
ment screening and referral pathways [29]. To support
the introduction of the plan, the LVSW provided
mandatory training to all practitioners in 2018.
Prior to the training, we sought to understand eye care
practitioners’ views on addressing depression in people
with low vision [25]. Common barriers cited were lack
of knowledge about and confidence in depression identi-
fication and referral pathways, fears of ‘doing more harm
than good’ and patient reluctance to discuss depression.
Similar barriers were identified among Australian eye
care staff and rehabilitation workers [30], who requested
training in the use of a depression screening tool and
clear referral pathways to improve their confidence [31].
Following training, these participants were more likely
to use a screening tool and to refer depressed patients to
the GP. However, time constraints, negative emotions
anticipated during screening, limited referral options
and patient reluctance to accept a referral remained key
barriers to implementation [32]. Given the complexity of
depression screening in low vision services, the aim of
the study is to examine the integration of routine
screening and referral pathways into a national low vi-
sion service in Wales at 6 months following practitioner
training, and to identify key barriers to implementation.
Methods
Study design and participants
The LVSW is a national community-based service deliv-
ered in optometry practices. It supports individuals with
low vision by promoting independence through the pre-
scription of devices such as magnifiers, and by making
referrals to outside agencies including voluntary organi-
sations, social care and healthcare professionals. The ser-
vice is provided by optometrists, dispensing opticians or
ophthalmic medical practitioners who have undergone
the Professional Certificate in Low Vision [33]. The re-
search was granted ethical approval from the School Re-
search Ethics Audit Committee at the School of
Optometry & Vision Sciences, Cardiff University (ref.
1457/1472). All participants were given information
sheets about the study prior to providing consent and all
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practices followed the guidelines of the Declaration of
Helsinki [34].
The study utilised data from a broader pre-post single
group study conducted by the same research team [25]. A
convergent mixed methods design was employed to provide
a comprehensive understanding of practice [35] (Fig. 1).
Quantitative questionnaire data were collected to investigate
general trends in practice and qualitative interviews provided
in-depth insights into practitioners’ experiences. The two
datasets were integrated to allow for comparisons between
them [36]. The broader study described the practitioners’
baseline levels of perceived barriers in addressing depression,
and their practice related to this prior to undertaking any
training. This study reports changes directly following the
LVSW training programme and 6 months later.
All practitioners were eligible (n = 193) excluding (n =
12) those who had previously completed training on de-
pression for another research study [37] and the Clinical
Lead for the service (author RB). Each practitioner was in-
vited to take part in either the survey or the interview, to
reduce burden and prevent contamination of responses.
LVSW depression guidelines and training programme
The LVSW depression management guidelines recom-
mend that practitioners screen all low vision patients for
depression using the two Whooley questions [38], (a
simplified version of the PHQ-2) [26]. The questions
are:
1) During the past month, have you often been
bothered by feeling down, depressed or hopeless?
2) During the past month, have you often been
bothered by having little interest or pleasure in
doing things?
If a patient answers ‘yes’ to either question, the practi-
tioner should discuss this with them and offer referral to
their GP for evaluation of possible depression.
The Whooley tool was chosen for its psychometric
properties and ease of implementation [39], and because
it is the tool recommended for use by healthcare practi-
tioners in the NICE guidelines [28]. Both the PHQ-2
and Whooley questions showed good diagnostic per-
formance in older people [40], however, given the latter
is easier to implement (requiring no scoring), it is rec-
ommended as the preferred tool in clinical practice [40].
The combined sensitivity and specificity for the Whooley
questions across six studies with older people was previ-
ously found to be 0.92 (95% CI 0.85 to 0.96) and 0.68
(95% CI 0.58 to 0.76) respectively, and for those with
Fig. 1 Convergent mixed methods design
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chronic illness, sensitivity and specificity of 0.98 (95% CI
0.85 to 0.99) and 0.86 (95% CI 0.70 to 0.94) was found
respectively [39].
The mandatory training comprised of an online lecture
(1 h) by a Consultant Psychiatrist, providing an overview
of depression, its relevance to low vision, clinical guide-
lines and screening procedures. This was followed by at-
tendance at a face-to-face workshop (1.5 h). The
workshop was designed to introduce practitioners to the
service guidelines and enhance their confidence in dis-
cussing depression and making a referral to the GP.
Measures
A questionnaire was used to collect information on 1)
participant demographics and employment characteris-
tics, 2) clinical practice of identifying depression (2 ques-
tions), 3) ‘actions taken in response to suspected
depression’ (8 item scale e.g. “Discuss their feelings with
them”) and 4) ‘perceived barriers to working with people
with depression’ (13 item scale e.g. “My limited know-
ledge of depression means that patients may not always
receive the best management for depression”). Responses
to the latter two scales were provided on a Likert scale
i.e. strongly agree, agree, disagree, strongly disagree. The
questionnaire was originally developed for completion
by eye care professionals, refined using Rasch analysis
and validated in previous research (for a full description
of the questionnaire development, see Rees et al. [41]).
Responses to the questionnaire were obtained pre-
training (March 2018) to establish baseline levels and
repeated at 6 months post-training (January 2019) to
identify changes in barriers and practice following the
programme (medium-term follow up). The perceived
barriers scale was also administered immediately post-
training (July 2018) to determine whether the training
programme immediately overcame any barriers, for ex-
ample, lack of knowledge of which screening tool to use.
To maximise ease of completion and response rates, On-
line Surveys [42] was used to develop and host an online
version of the questionnaire. This was iteratively tested
to identify and correct errors, to ensure optimum data
quality.
Qualitative interviews
A semi-structured interview guide was developed by au-
thor CN and was based around the key topics within the
questionnaire, so that the data from the two could be in-
tegrated. The guide was refined following piloting with a
low vision practitioner and input from the research team
and Qualitative Research Group (Centre for Trials Re-
search, Cardiff University). Prompts were added to elicit
information in the case that participants were not forth-
coming. The final guide consisted of four key questions,
followed by several follow-up questions and requests for
examples, concerning the identification and manage-
ment of depression in low vision patients and perceived
barriers to addressing depression in low vision.
Procedures
Participants who had completed a pre-training qualitative
interview as part of the wider study [25] (N = 12) were in-
vited by email to take part in a follow-up interview, 6
months after the training. Participants were selected for
the interviews using a maximum variation strategy with
the purpose of eliciting the views of practitioners with a
range of characteristics and experience [43]. Interviews
were conducted by CN, a female psychology graduate and
experienced mental health researcher interested in the as-
sociation between vision loss and mental health. CN was
independent of the LVSW and unknown to the practi-
tioners. Interviews were undertaken either face-to-face in
the practitioner’s place of work or in a university office, or
by telephone, and lasted between 30 and 56min. Field
notes and a reflexive journal were kept throughout the
interviewing and analysis process.
All other eligible practitioners were invited by the LVSW
Clinical Lead to take part in the online questionnaire (N=
167). Practitioners were emailed a link along with an introduc-
tion to the study and the Participant Information Sheet. They
were informed that they could complete the questionnaire
solely as a pre-training reflection task (a standard aspect of
LVSW re-accreditation training) or could check a box to indi-
cate their consent for their answers to be used for research
purposes. Practitioners were asked to provide a pseudonym to
anonymise their responses, which could then be linked across
the three time points. Anonymity was considered important
to reduce perceived pressure to consent and to maximise the
likelihood of honest responses. Further links to the question-
naire were sent immediately following the face-to-face training
and 6 months post-training. At each time point, a reminder
email was sent to maximise participation.
Analysis
Psychometric assessment of questionnaire scales
Rasch analysis was used to assess the psychometric
properties of the ‘actions taken in response to suspected
depression’ and ‘perceived barriers’ scales using the
Andrich rating scale model [44] with Winsteps software
(version 3.92.1), Chicago, Illinois, USA. Since participant
scores are ordered counts, uneven and non-linear, a sim-
ple summation of raw scores and/or reporting of pro-
portions as is traditionally carried out is demonstrably
flawed [45]. Rasch analysis, a form of Item Response
Theory (IRT), was undertaken to transform these or-
dered responses to estimates of interval measures
(expressed in log of the odds units, or logits). Once the
data fit the Rasch model, person measures in logits were
extracted for further analysis. During Rasch analysis,
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responses were recoded so that higher scores indicated
greater willingness to act in response to perceived de-
pression in low vision patients (“action taken” scale) and
greater perceived barriers in working with low vision pa-
tients with depression (“perceived barriers” scale), re-
spectively. To generate valid pre-post person measures,
data were stacked and anchored to item calibrations at
baseline [46]. DIF was assessed for age (median split <
44 years vs. ≥44 years), gender, data collection time
points (baseline, post-training, follow-up) and whether
the practitioner had previously received training in the
identification and management of depression.
Statistical analysis
STATA Version 13 (StataCorp LLC, TX, USA) was used
to analyse the questionnaire data. Participants who com-
pleted the questionnaires at all three time points consti-
tuted the final sample and were included in the analysis.
Descriptive statistics were used to describe their demo-
graphic and work characteristics and their reported
practice around the identification of depression. Cat-
egorical variables were summarised as numbers and per-
centages whilst continuous variables were presented as
medians with interquartile ranges.
Two multi-level linear regression analyses (multiple
timepoint observations clustered within person) were con-
ducted to determine the difference in scores over time for
the ‘action taken in response to depression’ scale and the
‘perceived barriers’ scale (reference category: pre-training).
A further multi-level linear regression was performed to
examine the relationship between perceived barriers and
action taken. No other variables were entered into the
model. The two-tailed p-values and 95% confidence inter-
vals of each analysis are presented with p-value < 0.05
considered statistically significant.
Qualitative analysis
A professional company transcribed the audio-recorded
interviews verbatim. The interviewer checked the tran-
scriptions for accuracy before analysing the data using a
codebook approach to Thematic Analysis [47]. The first
step was familiarisation with the data through repeatedly
reading each transcript. Initial codes were then gener-
ated inductively from the data and recorded on each
transcript, before being transferred to electronic copies
stored in NVivo (Version 11) where they were organised
(eg grouped, renamed or divided). They were subse-
quently grouped under three themes, mirroring three
sections of the questionnaire: identification of depres-
sion, action taken in response to suspected depression
and perceived barriers to working with people with
depression. This facilitated integration of the two sets
of data. Sub-themes were generated inductively from
the data.
To ensure rigour, the codes and sub-themes were
checked against the interview transcripts, the inter-
viewer’s reflexive journal and discussed with the research
team to ensure they remained true to the original data.
They were then written into narratives evidenced by data
extracts. The analysis was approached from a realist per-
spective and codes were developed at a semantic level,
by examining the surface meaning of the data [48].
Mixed methods integration and analysis
In a convergent design, integration is a process of com-
bining the quantitative and qualitative data to enhance
understanding and validate the results [36]. Integration
occurred both at the methods level, through basing
interview questions on the questionnaire sections, and at
the results level, through merging [36, 49] questionnaire
and interview findings. When merging the two sets of
results, four possible outcomes were considered [50]: 1)
Confirmation, when the quantitative and qualitative find-
ings lead to the same interpretation 2) Complementarity,
when the two sets of data show different, non-
conflicting conclusions 3) Expansion, when the datasets
provide a central overlapping theme and a broader non-
overlapping interpretation 4) Discordance, when the two
datasets lead to conflicting interpretations.
Results
The psychometric assessment of the two questionnaire
scales are reported first, followed by the main results
centred around the four sections of the questionnaire.
For each section, we present the questionnaire data,
followed by the corresponding interview data and mixed
method outcomes where applicable.
Psychometric properties of questionnaire scales
Initially, both scales displayed poor fit to the Rasch
model, with suboptimal precision, evidence of multidi-
mensionality (> 1 construct being assessed) and DIF, as
well as misfitting items. After iterative removal of misfit-
ting items and those displaying DIF (2 items from the
action in practice scale and 3 items from the barriers
scale), the two questionnaire scales displayed adequate
psychometric properties with ordered response thresh-
olds, good precision (able to distinguish at least 3 levels
of participant ability), no misfitting items or DIF, and
importantly, no evidence of multidimensionality. The
difference between item difficulty and person ability for
both scales was minimal, indicating that the items were
suitably targeted to the participant population. Person
measures (in interval level log-odds units [logits]) were
then exported for use in subsequent parametric testing.
The mean person measures (±SD) at baseline were −
1.38 (2.30) logits and − 0.47 (1.37) logits for the “action
taken” and “perceived barriers” scale respectively, while
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the mean scores at 6 months follow-up were 1.39 (2.30)
logits and− 1.42 (1.65) logits respectively i.e. there was more
action and less perceived barriers at 6 months (Table 3).
Demographic and employment characteristics
A total of 40 participants completed all three question-
naires, with their results utilized in the pre-post quanti-
tative analyses. Their baseline demographic and
employment characteristics of these participants are pre-
sented in Table 1.
Nine of the 12 practitioners approached completed a
qualitative interview: of the remaining three, one was on
maternity leave and two agreed to a second interview
but could not schedule one during the data collection
period. Interview participants’ characteristics are pre-
sented in Table 1.
Identification of depression
The number of practitioners who indicated on the ques-
tionnaire that they aimed to identify depression in-
creased from 15 (37.5%) at pre-training to 37 (92.5%) at
6 months post-training, with 35 (87.5%) reportedly using
the two Whooley questions. Whilst only 4 (10%) re-
ported using any screening questions more than ‘rarely’
prior to the training, 32 (80%) reported doing so 6
months post-training (Table 2). However, only 13
(32.5%) reported doing so ‘always/almost always’, as per
the service guidelines.
Amongst the interview participants, the most com-
monly reported outcome of the training programme was
an increased awareness of the prevalence of depressive
symptoms in people with low vision. As a result, some
practitioners had started to enquire about how patients
were feeling.
“I think I try to be more aware and look at the
patient and question them about how they feel.” P05
Practitioners adapt the guidelines The service guide-
lines require that all patients are screened. Eight of the
practitioners acknowledged this guideline but had mixed
views about its utility. They shared two variations to its
implementation. Firstly, the majority did not screen
every patient, reporting that they considered it inappro-
priate to ask the two questions of people who they con-
sidered to seem well or healthy, which they judged from
behavioural cues and conversation.
“…. I would say that, er, I probably ask that (the
screening tool) to about half of them …. if they seem
to be, um, absolutely on top of the moon, and bub-
bly, positive, and, um, everything I just have a feeling
that there isn’t anything to it. There’s no point in
asking it.” P08
Secondly, only one practitioner asks the two questions
exactly as worded. The remainder revealed that they
change the wording or ask similar questions instead,
mainly to avoid using the words ‘depressed’ or ‘hopeless’
which are viewed as ‘loaded’ or ‘taboo’. Some practitioners






Male N (%) 14 (35.0) N 5
Female 26 (65.0) 4
Professional Background
Optometrist/Ophthalmic medical practitioner N (%) 37 (92.5) N 7
Dispensing optician 3 (7.5) 2
Time employed as LVSW practitioner (years) Median (IQR) 10.0 (6.5–12.0) Range 1–12
Average number of people with low vision seen each month Median (IQR) 5.0 (4.0–12.0) Range 1–60
Average time spent with patient with low vision (mins)
Less than 10 N (%) 0 (0.0) N 0
11–20 0 (0.0) 0
21–30 3 (7.5) 0
31–40 9 (22.5) 1
41–50 16 (40.0) 3
51–60 10 (25.0) 5
More than 60 2 (5.0) 0
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fear that by talking about depression they could “make
matters worse” (P05) or stir up difficult feelings.
“I try and avoid using it (depression) directly, espe-
cially too early on in the conversation. I think it's a
very taboo word these days isn't it? … .I try and just
talk about things like the sort of moods and feelings
and things like this, rather than depression itself.”
P03
“ … .I’m worried about bringing up the big depres-
sion word with patients, I’m worried about causing
more trouble.” P07
In addition, practitioners perceive that asking the ques-
tions word-for-word appears unnatural, robotic or like a
‘tick box’ exercise, and prevents the smooth integration of
depression screening into the assessment. Instead, they
ask the questions in their own way, perceiving that con-
veying the gist of the questions is sufficient.
“I don’t word it exactly as heard, I think it might
sound a bit robotic if I did … … erm, but I try to
make sure that I, I get the main focus or point of the
sentence or question across.” P07
Appears acceptable to patients Most practitioners had
found a way to introduce questions about emotional health
when they felt it was appropriate and usually incorporated
this into the typical history and symptom taking. Seven ex-
plained that despite their concerns, questions about mood/
depression seemed to be acceptable to patients. Moreover, in
some cases, patients who were feeling depressed, expressed
relief and gratitude at being encouraged to talk about it. This
reinforced the need for discussions with future patients.
“ … d’you know, I’ve not had one single negative
response?.....But there's been a lot of people who’ve
just been really grateful” P11
Mixed method outcome Confirmation. The two sets of
results confirmed that more practitioners aimed to
identify depression after training and were using the
screening questions to do so, but not at every assess-
ment. The interviews revealed that the majority only use the
screening questions when they feel it is appropriate, and they
adapt the wording of the questions at their discretion.
Action taken in response to suspected depression
The results demonstrate a statistically significant in-
crease in practitioners’ total score on the ‘action taken in
response to suspected depression’ questionnaire scale
(Table 3), indicating that practitioners reported taking
more action than before training. At both time points,
practitioners were most likely to discuss the patients’
feelings with them, discuss a GP referral and refer to the
GP. They were least likely to refer patients to a mental
health service. For the full range of responses see Add-
itional file 1 - Supplementary Figure 1.
The linear regression to examine the relationship be-
tween barriers and action taken revealed that practi-
tioners who perceived more barriers took less action in
response to suspected depression (beta coefficient = −
0.805, 95% CI − 1.133 to − 0.477, p < 0.001).
In responding to possible depression, most practi-
tioners who were interviewed considered that the usual
activities undertaken in a low vision assessment could be
enough to have a positive impact on mood. For example,
improving visual function through rehabilitation can en-
able engagement in valued activities and signposting to
social care organisations can facilitate additional
support.
“..now you think how, um, people's loss of vision im-
pacts on sort of … .their mood if you like. Um, and
then it also makes you realise what a difference you
can make by getting them to see better … .” P04
Few GP referrals made In addition to improving visual
function, discussing a GP referral was the most common
action taken in response to suspected depression; how-
ever, its implementation differed among practitioners.
Some solely advised the patient to visit the GP, whilst
others discussed a referral with the patient and indicated
they were “happy to write a letter” (P12) if the patient
agreed. However, following through with a referral was
uncommon, sometimes because the patient was already
under the care of the GP, but more often because the
patient reportedly declined the referral.
“They're usually fairly unmotivated … ..to get them-
selves sorted” P03
“It's so hard sometimes, just to get people to accept
help” P04
Table 2 Frequency of using a screening tool to identify
depression before training and 6 months post-training
Pre-training Six months post-training
n % n %
Never/rarely 36 90 8 20
Less than half the time 1 2.5 7 17.5
More than half the time 3 7.5 12 30
Always/Almost always 0 0 13 32.5
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Practitioners reported being more likely to make a re-
ferral when they suspected a patient was seriously de-
pressed or suicidal.
“If I thought they were really totally depressed, and I
was worried for them, then I would contact the GP,
and make a referral just to say, I've seen this patient,
I think she has a lot of difficulties, in coping, and I
would like your opinion.” P05
Mixed methods outcome Confirmation & Expansion.
The questionnaire outcomes indicated an increase in
action taken, with discussing feelings and a GP refer-
ral being more likely than mental health referrals.
The interview data confirmed that discussions about
GP referrals commonly occurred and additional infor-
mation about the barriers to referral was gained. Re-
ferral to social care and other activities to promote
visual function were viewed as having the potential to
influence mood, which was not measured on the
questionnaire.
Perceived barriers to working with people with
depression
The total scores on the ‘perceived barriers’ questionnaire
scale decreased significantly between pre- and post-
training, with a further significant decrease at 6 months
(Table 3.) The most commonly endorsed barrier at each of
the time points was the patients’ reluctance to discuss how
they feel. Supervisor support, workplace environment and a
need to protect oneself from patients’ emotional problems
were the least endorsed barriers. For the full range of re-
sponses see Additional file 2 - Supplementary Figure 2.
Patients themselves are a barrier In the interviews,
the most commonly perceived barrier to addressing
depression in patients with low vision was ‘the patient
themselves’. Patients were perceived as being reluctant
to talk about depression, due to the sensitive nature
of the topic and a view that it is a sign of weakness.
“ … a lot of people that come in are very, very brave,
stiff upper lip and all that, and they don’t share
much with you.” P04
However, this was a motivating factor for one partici-
pant to ask everyone the screening questions, rather
than rely on the patient to initiate a discussion about
mood:
“I do make a point (of asking everyone) because I’m
aware that so many people won't bring it up them-
selves for reasons, for a million reasons, I suppose, if
they were either ashamed or just trying to deny it, or
didn’t feel like it was my place to discuss it with
them … .so you have to do it for them.” P11
The perception that individuals can mask depression
is seen as a barrier to identification. Practitioners re-
ported being unsure how to negotiate situations in
which the patient reported being fine, but they suspected
otherwise. This is particularly an issue for those who do
not ask the two questions, but rather rely on their intu-
ition or indirect questioning.
“Barriers? … I think sometimes, erm, you know if
someone’s depressed and they put on a sort of façade
of a bubbly, bon homie, um … and maybe I’m not as
good at identifying that.. … probably I should ask
everybody that (screening) question ...” P08
Most practitioners perceive that, in general, patients
are reluctant to accept help for emotional difficulties
which then makes instigating a referral to the GP diffi-
cult. It was acknowledged that simply advising the pa-
tient to visit their doctor was not enough to lead to any
action, but that a formal referral cannot be made with-
out the patient’s consent.
Table 3 Mean scores for questionnaire scales & linear regression to determine difference in score over time
Scale Timepoint Mean SD Linear Regression
Difference in means 95% CI p-value
Action taken Pre-training −1.382 2.3073 Reference category
Follow-up 1.386 2.3030 2.768 1.925 to 3.611 < 0.001
Log likelihood = − 177.608; Wald χ2 = 41.42, p < 0.001
Perceived barriers Pre-training −0.474 1.3793 Reference category
Post-training −1.121 1.4637 −0.647 −1.012 to − 0.282 0.001
Follow-up −1.424 1.6457 −0.950 −1.315 to − 0.585 < 0.001
Log likelihood = − 188.596; Wald χ2 = 27.15, p < 0.001
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“Oh yeah, yeah, no problem if someone’s happy for
me to refer them, no problem at all. Erm, I think, I
mean the only barrier is the patient themselves, I
guess, if they decline then I can’t really deny that”
P07
Discussing support options and gaining consent was
an area in which practitioners wanted further training.
Service barriers A few practitioners reported the lack of
time is a barrier and “some things can take more precedence”
(P04) over depression screening in low vision assessments.
They explained that when patients openly discuss their men-
tal health, appointments can take longer than usual and im-
pact on clinic management. However, others felt they did
have enough time, and certainly more than GPs, and were
therefore well placed to ask about mental health. Long wait-
ing times for mental health services and perceived lack of ac-
tion by GPs were seen as barriers to obtaining support for
patients, over which they had no control.
“ … it’s things that are outside my control perhaps. I
mean I know obviously we all hear about the NHS
and the issues and I know about mental health
waiting times and I know about, erm, lack of re-
source funding etc. I, I can’t think of, of anything to
fix that.” P07
“I have had two patients, um, recently that I’ve seen
now for the second time … .where I’ve made a refer-
ral for depression. Um, and I’ve said, “Oh,” you
know, “what happened after that, then?” And both of
them said, “Nothing.” P11
Practitioner lack of confidence For some practitioners,
lack of confidence was less of a barrier than at pre-
training, because they felt more certain about how to
identify and discuss depression.
“I think the barriers that I had before was that I
didn’t know the right way to go about asking, and
now I feel happy that I have the two questions, um,
so I know, I know how to approach it.” P12
However, confidence remained a barrier to addressing
depression for those who do not feel comfortable asking
the two questions and or in gaining consent for a refer-
ral to the GP.
“Um, how do I convince them that it would probably
be better if I did the referral, rather than just relying
on them to go (to the GP)” P03
Mixed methods outcome Confirmation. The two data-
sets confirmed that overall barriers to working with pa-
tients with depression decreased, and that the key
remaining barrier was perceived patient reluctance to
talk about depression or to accept help.
Discussion
This study examined the integration of depression
screening and referral pathways into the LVSW. Import-
antly, we found that over 90% of practitioners aimed to
identify depression in their patients following training,
compared with only one third beforehand. Most re-
ported using the recommended Whooley questions to
do so. However, only a minority used the screening
questions with all patients, despite the specification to
do so in the service guidelines, based on their perception
that it is inappropriate to screen people who seem
healthy and well. In addition, the majority of practi-
tioners did not consistently ask the questions as phrased.
Instead, practitioners modified the wording because of a
fear that direct conversations about depression may
make matters worse, and to prevent screening from
appearing like a ‘tick box’ exercise. Despite practitioners’
concerns about addressing depression, the majority per-
ceived that patients accept being questioned about their
mood and some even showed relief or gratitude.
Practitioners took significantly more action to address
possible depression following the training. Those who
perceived fewer barriers were more likely to take action
such as discussing the patients’ feelings with them, and
offering and making a GP referral. However, interview
participants revealed that discussions about referral are
not straightforward and gaining consent can be difficult
due to their patients’ general reluctance to accept help.
Referrals for perceived cases of severe depression or sui-
cidal ideation were more likely than for more moderate
cases. A further course of action taken concerned im-
proving visual function, which some practitioners be-
lieved to be the cause of, and therefore the solution to,
depression.
Overall perceived barriers to addressing depression re-
duced significantly. Although practitioners gained in
confidence, the key remaining barrier was perceived to
be ‘the patient themselves’. Specifically, patients’ appar-
ent reluctance to discuss their feelings and to accept
support. Some practitioners believed people can hide de-
pression well, making it difficult to identify. Failure to
screen every patient may compound this issue. Other
barriers cited were limited appointment times leading to
prioritising eye related matters, and issues beyond the
practitioners’ control such as long waiting times for
mental health services and lack of treatments offered by
the GP.
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Our findings align with previous work, in which brief
training programmes for Australian eye health and re-
habilitation workers reduced their perceived barriers and
increased their likelihood of responding to depression
[32, 41]. Staff were less likely to report that lack of skills,
training and ability to identify depression were barriers
at post- compared to pre-training, but as with our find-
ings, time constraints and patient unwillingness to
accept a referral remained key concerns. The Australian
studies [32, 41] assessed the impact of training at only
one timepoint (on completion of the training), and uti-
lised only quantitative data. As suggested by the authors
of the two studies, we have conducted a 6 month follow-
up evaluation and used interviews to supplement
questionnaire measures in the present study, thereby ex-
tending the evidence base.
The wider literature on depression screening in gen-
eral healthcare settings similarly identifies considerable
barriers. Low rates of screening have been reported
across primary care [51], physiotherapy [52] and
hospital-based stroke services [53], even when staff have
received specific training or are incentivised. Consistent
with our findings, one of the main barriers reported by
primary care practitioners is the desire to avoid a ‘tick
box exercise’ and their subsequent struggle to align the
use of a screening tool with a patient-centred approach
[14, 54, 55]. Practitioners across healthcare settings re-
ported: using a standardized test only with people they
suspected were depressed [53]; avoiding asking screening
questions if they were familiar with the patient [55]; and
adapting the questions to suit their consultation style
[54–56]. Furthermore, use of the Whooley questions in
routine practice has been shown to miss cases of depres-
sion, which may be due to variations in how the ques-
tions are asked [56]. In addition, nurses expressed
discomfort with asking the two questions, suggesting it
was like ‘opening a can of worms’ which was difficult to
address in the allotted assessment time [54, 55].
Concerns over patient reticence to discuss depression
also permeate the wider literature [14, 54, 55]. For ex-
ample, patients with long term conditions screened for
depression in primary care did not understand why they
were being screened which led to some giving defensive
answers [55]. In maternity services, patients were less
likely to disclose depression when it was felt that staff
were unconfident or ‘going through the motions’ [57].
Conversely, patients with low vision being screened for
depression responded positively to the process [58].
Implications for practice
The complexity of integrating two depression screening
questions into a low vision, or any healthcare/rehabilita-
tion setting should not be under-estimated. Alderson
et al. [55] recommended patients, professionals and the
service should be fully prepared. Whilst our guidelines
and training proved helpful, future training should have
a stronger focus on how to integrate the screening into
the assessment in a patient-centred way. This might be
achieved through role play, ideally with professional ac-
tors taking the part of patients. Enhanced knowledge of
treatment options and outcomes offered by the GP may
increase confidence in discussing and gaining consent
for a GP referral.
Patients could be prepared either by careful introduc-
tion and explanation of the questions during the assess-
ment, or via information sent out prior to their
appointment. This may help reduce feelings of shame
and enable patients to discuss depression [19]. Finally,
service preparation may include the consideration of ex-
tended assessment times, adding the screening questions
to assessment schedules and providing ongoing support
for practitioners.
Patient outcomes also need to be considered. In this
study, we did not record the impact of screening and/or
referral on depression. The evidence as to whether sim-
ply referring to the GP leads to improvements in depres-
sion for people with vision impairment is mixed [8, 37].
Identifying positive cases may be of little benefit if there
are no effective assessment or treatment services avail-
able [39]. Instead, it may be more prudent to focus on
interventions for the prevention of depression in this
high risk group [59]. In addition, screening in primary
care may provide further opportunities for detection and
treatment.
Strengths and limitations
Unlike many previous studies in low vision, we conducted
a medium-term follow-up. Therefore, participants were
able to report changes incorporated into their practice, ra-
ther than their intention to change. Use of a mixed
methods design provided a comprehensive understanding
of practice and overcame the potential limitations of using
either quantitative or qualitative methods alone. The two
datasets confirmed each other, suggesting valid and cred-
ible results, and the interview data explained some of the
questionnaire findings. The questionnaire data were trans-
formed from ordinal to interval-level responses using
Rasch analysis and the reliability of the questionnaires was
demonstrated. Anonymous completion of the question-
naires may have facilitated more honest answers than
otherwise expected.
The study is limited by the absence of a control group
and we cannot be sure that any changes which occurred
were due solely to the introduction of the guidelines and
training programme. A valid control group was not feas-
ible for this study, as all LVSW practitioners underwent
mandatory training. Despite this, only around a quarter
completed a questionnaire at all three time points and
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were included in the study. We do not have any infor-
mation on those who were not included, therefore there
may be a risk that the completers differed from the non-
completers. However, our rich qualitative dataset sup-
ported the questionnaire results, suggesting our findings
are representative of practitioner views. The results from
the nine participants who were interviewed at follow-up
may be subject to selection bias inherent in agreeing to
take part and more interviews would have enabled
greater data saturation. The study relied on self-report
data to assess change in practice. Despite anonymous
completion, this method of data collection is still open
to bias. Further studies would benefit from using routine
data or observing clinical practice.
Conclusions
The introduction of depression screening guidelines and
training successfully increased the number of practi-
tioners identifying and addressing depression in individ-
uals attending the low vision service. However,
standardized screening of all attendees to the service
using the two Whooley questions has not yet been
achieved and several practitioner, patient and service
barriers remain. Further research could focus on the
process from the patients’ perspective, to determine the
desire for and acceptability of screening. More work is
needed to understand the impact of screening and refer-
ral on patient outcomes.
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